Henry Ford Health System (WDIV)
Henry Ford Health System (WDIV)

DETROIT— Henry Ford Health System will release the first massive U.S. study to figure out a drug’s efficiency in preventing coronavirus (COVID-19).

The study will check an anti-malarial drug in avoiding COVID-19 in healthcare workers and very first responders who volunteer to take part.

Since Thursday, Henry Ford healthcare facilities were caring for 624 COVID-19 patients.

The research study of hydroxychloroquine utilized prophylactically might begin as early as next week, according to Henry Ford.

” This is going to be the very first significant, conclusive research study in health care workers and very first responders of hydroxychloroquine as a preventative medication,” stated the study’s organizer, Henry Ford Health System’s Dr. William W. O’Neill, a world-renowned interventional cardiologist and scientist who has actually pioneered multiple treatments for heart disease. “There has been a great deal of talk about this drug, however only a little, non-blinded study in Europe. We are going to change that in City Detroit and produce a clinical answer to the question: Does it work?”

Related: Michigan coronavirus (COVID-19) cases as much as 10,791; Death toll now at 417

Participation in the research study is strictly on a volunteer basis. Dr. Marcus Zervos, division head of Contagious Illness for Henry Ford Health System, will manage this study with Dr. O’Neill.

” We are thankful to see Henry Ford’s lead on this volunteer research study that might assist safeguard medical employees and first responders throughout southeast Michigan,” Mayor Duggan stated, acknowledging U.S. Food & Drug Administration Commissioner Dr. Stephen M Hahn “I likewise deeply value Dr. Hahn’s prompt support for this important effort.”

Both health care employees and first responders will be enrolled at Henry Ford Hospital Detroit. Currently, there are no FDA-approved treatments to avoid or treat COVID-19 According to the U.S. Centers for Disease Control & Prevention, hydroxychloroquine (also referred to as hydroxychloroquine sulfate) is an FDA-approved arthritis medication that likewise can be utilized to prevent or deal with malaria. It is readily available in the United States by prescription only.

The drug is offered under the brand Plaquenil and it is likewise sold as a generic medicine. It is commonly used by patients with arthritis, lupus or other rheumatic conditions.

” Metro Detroit has a history of stepping up when things get tough,” said Dr. Adnan M